VTGN: VistaGen Therapeutics Inc

VTGN新闻

• 17:06 12 Health Care Stocks Moving In Thursday's Intraday Session
• 17:06 周四盘中交易中表现突出的12家医疗保健股
• 11:09 Vistagen Presents Exploratory Data At Psych Congress 2026 Highlighting Potential Efficacy Signal For Phase 3 Fasedienol Nasal Spray In Patients With Very Severe Social Anxiety Disorder
• 11:09 维斯塔根在2026年精神学大会上展示初步数据，突显Fasedienol鼻喷剂在极度严重社交焦虑症患者中可能具有潜在疗效信号的临床三期试验。
• 17:06 12 Health Care Stocks Moving In Wednesday's Intraday Session
• 17:06 周三盘中表现活跃的12家医疗保健股
• 13:25 Penny Stock Vistagen Analyst Highlights Caution after Anxiety Data
• 13:25 Vistagen股票分析师在焦虑数据公布后强调谨慎态度
• 12:06 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
• 12:06 周三盘前市场活跃的12只医疗保健股
• 12:30 Vistagen Says Fasedienol Well-Tolerated Up To 12 Months In Preliminary Open-Label Extension Of Phase 3 Social Anxiety Trial; Plans FDA Meeting This Quarter On New Phase 3
• 12:30 Vistagen表示Fasedienol在初步开放标签延伸的3期社交焦虑试验中耐受性良好，长达12个月；计划在本季度就新的3期试验与FDA会面
• 18:12 Vistagen Therapeutics, Inc. (VTGN) Discusses PALISADE-4 Phase III Results and Post-Hoc Analyses in Social Anxiety Disorder Transcript
• 21:15 Veeva Systems (VEEV) Q1 Earnings and Revenues Surpass Estimates
• 21:40 HealthEquity (HQY) Q1 Earnings and Revenues Top Estimates
• 12:15 Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates
• 13:00 Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates